{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-21-001070","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2021-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.732740+00:00","generated_at":"2026-06-28T16:12:00.788768+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeloc reports Q3 revenue up 21% YoY; net income of $0.21/share vs loss year ago","bullets":["Q3 2021 net revenue $1.887M (+21% YoY); net income $523k ($0.21 diluted EPS) vs loss of $0.09/share in Q3 2020.","Nine-month 2021 revenue $5.427M; net income $816k ($0.33 diluted EPS) vs loss $0.30/share prior year.","Results include $471k PPP loan forgiveness in Q3; total $936k for nine months.","Refinanced building mortgage from 4.00% to 2.95% fixed rate through Sept 2031.","New L-series devices (LX9, LT7) driving demand; R.A.D.A.R. 200 field testing; SpinDx breathalyzer expected revenue by late 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-21-001070","json":"https://secwatch.observer/filing/0001079973-21-001070.json","markdown":"https://secwatch.observer/filing/0001079973-21-001070.md","text":"https://secwatch.observer/filing/0001079973-21-001070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997321001070/0001079973-21-001070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997321001070/lclc_8k-q3.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:12:00.788768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}